title: Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation.
authors.affiliation: Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA.
authors.forename: N T
authors.initials: NT
authors.lastname: Oliver
authors.affiliation: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Y L
authors.initials: YL
authors.lastname: Nieto
authors.affiliation: Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: B
authors.initials: B
authors.lastname: Blechacz
authors.affiliation: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: P
authors.initials: P
authors.lastname: Anderlini
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: E
authors.initials: E
authors.lastname: Ariza-Heredia
authors.affiliation: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: H A
authors.initials: HA
authors.lastname: Torres
mesh_terms: D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006526:Hepatitis C / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008297:Male; D019172:Transplantation Conditioning / Q000009:adverse effects*